Financial

News

Investors take issue with Taisho Pharma’s buyout price

Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court, after failing to reach an agreement on the price.

News

Private equity firms ‘eyeing $20bn for Sanofi consumer unit’

Private equity firms Bain Capital and Cinven are reported to be considering a bid for Sanofi’s consumer health business, according to Bloomberg.

News

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

Bayer’s first-quarter results update shows that its workforce has declined by more than 1,500 full-time equivalent (FTE) employees since the end of last year, suggesting r

News

Wegovy sales double, as starting restrictions start to lift

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy

News

GSK turning a corner as sales, profits forecasts rise

GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales

News

Alzheimer’s drug Leqembi moves forward, still in low gear

Biogen has given an update on the rollout of its Eisai-partnered Alzheimer’s disease therapy Leqembi alongside its first-quarter results, showing that while the drug’s tak

Investors take issue with Taisho Pharma’s buyout price

Private equity firms ‘eyeing $20bn for Sanofi consumer unit’

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

Wegovy sales double, as starting restrictions start to lift

GSK turning a corner as sales, profits forecasts rise

Alzheimer’s drug Leqembi moves forward, still in low gear

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks